Published in FEBS Lett on April 24, 1989
Expression of separate isoforms of human tau protein: correlation with the tau pattern in brain and effects on tubulin polymerization. EMBO J (1990) 3.36
The switch of tau protein to an Alzheimer-like state includes the phosphorylation of two serine-proline motifs upstream of the microtubule binding region. EMBO J (1992) 3.04
Mitogen activated protein (MAP) kinase transforms tau protein into an Alzheimer-like state. EMBO J (1992) 2.16
Difference between the tau protein of Alzheimer paired helical filament core and normal tau revealed by epitope analysis of monoclonal antibodies 423 and 7.51. Proc Natl Acad Sci U S A (1991) 1.41
Tau phosphorylation sites work in concert to promote neurotoxicity in vivo. Mol Biol Cell (2007) 1.37
Pathological proteins Tau 64 and 69 are specifically expressed in the somatodendritic domain of the degenerating cortical neurons during Alzheimer's disease. Demonstration with a panel of antibodies against Tau proteins. Acta Neuropathol (1990) 1.31
Topographical relationship between beta-amyloid and tau protein epitopes in tangle-bearing cells in Alzheimer disease. Proc Natl Acad Sci U S A (1990) 1.22
Identification of 3- and 4-repeat tau isoforms within the PHF in Alzheimer's disease. EMBO J (1991) 1.16
Correlation between microscopical changes and Tau 64 and 69 biochemical detection in senile dementia of the Alzheimer type. Tau 64 and 69 are reliable markers of the neurofibrillary degeneration. Acta Neuropathol (1990) 0.96
Familial FTDP-17 missense mutations inhibit microtubule assembly-promoting activity of tau by increasing phosphorylation at Ser202 in vitro. J Biol Chem (2009) 0.96
Tau in Alzheimer's disease and Down's syndrome is insoluble and abnormally phosphorylated. Biochem J (1991) 0.94
Massive accumulation of modified tau and severe depletion of normal tau characterize the cerebral cortex and white matter of Alzheimer's disease. Demonstration using the hydrated autoclaving method. Am J Pathol (1992) 0.86
Expression and phosphorylation of a three-repeat isoform of tau in transfected non-neuronal cells. Biochem J (1992) 0.82
Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies. Biomolecules (2016) 0.81
Tau pathology generated by overexpression of tau. Am J Pathol (1999) 0.77
Immunohistochemical and histopathologic correlates of Alzheimer's disease-associated Alz-50 immunoreactivity quantified in homogenates of cerebral tissue. Am J Pathol (1992) 0.75
Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res Brain Res Rev (2000) 5.40
Mice transgenic for the human myotonic dystrophy region with expanded CTG repeats display muscular and brain abnormalities. Hum Mol Genet (2001) 2.08
Alzheimer's disease: Tau proteins, the promoting factors of microtubule assembly, are major components of paired helical filaments. J Neurol Sci (1986) 1.69
Dysregulation of human brain microtubule-associated tau mRNA maturation in myotonic dystrophy type 1. Hum Mol Genet (2001) 1.62
Comparative biochemistry of tau in progressive supranuclear palsy, corticobasal degeneration, FTDP-17 and Pick's disease. Brain Pathol (1999) 1.53
Brain plasmin enhances APP alpha-cleavage and Abeta degradation and is reduced in Alzheimer's disease brains. EMBO Rep (2000) 1.49
A comparative study of histological and immunohistochemical methods for neurofibrillary tangles and senile plaques in Alzheimer's disease. Acta Neuropathol (1992) 1.49
Study of the 10-nm-filament fraction isolated during the standard microtubule preparation. Biochem J (1980) 1.49
Alzheimer's disease: A beta or ApoE amyloidosis? Lancet (1995) 1.39
Differential distribution of neurofibrillary tangles in the cerebral cortex of dementia pugilistica and Alzheimer's disease cases. Acta Neuropathol (1992) 1.38
Neurofibrillary degeneration in progressive supranuclear palsy and corticobasal degeneration: tau pathologies with exclusively "exon 10" isoforms. J Neurochem (1999) 1.33
Abnormal Tau proteins in progressive supranuclear palsy. Similarities and differences with the neurofibrillary degeneration of the Alzheimer type. Acta Neuropathol (1991) 1.28
Pathological alterations of the cerebral microvasculature in Alzheimer's disease and related dementing disorders. Acta Neuropathol (1994) 1.26
Pronounced impact of Th1/E47cs mutation compared with -491 AT mutation on neural APOE gene expression and risk of developing Alzheimer's disease. Hum Mol Genet (1998) 1.20
Distribution of cortical neurofibrillary tangles in progressive supranuclear palsy: a quantitative analysis of six cases. Acta Neuropathol (1992) 1.18
Glial reaction in the hippocampal formation is highly correlated with aging in human brain. Neurosci Lett (1997) 1.17
The polypeptides of isolated brain 10nm filaments and their association with polymerized tubulin. Biochem J (1979) 1.16
Characterization of two pathological tau protein, variants in Alzheimer brain cortices. J Neurol Sci (1989) 1.12
Brain microvascular changes in Alzheimer's disease and other dementias. Ann N Y Acad Sci (1997) 1.09
Specific tau variants in the brains of patients with myotonic dystrophy. Neurology (1996) 1.08
Distortion of allelic expression of apolipoprotein E in Alzheimer's disease. Hum Mol Genet (1997) 1.08
Could Wallerian degeneration contribute to "leuko-araiosis" in subjects free of any vascular disorder? J Neurol Neurosurg Psychiatry (1991) 1.07
Different distribution of phosphorylated tau protein isoforms in Alzheimer's and Pick's diseases. FEBS Lett (1997) 1.06
Overexpression of MBNL1 fetal isoforms and modified splicing of Tau in the DM1 brain: two individual consequences of CUG trinucleotide repeats. Exp Neurol (2007) 1.05
Hyperphosphorylated tau proteins differentiate corticobasal degeneration and Pick's disease. Acta Neuropathol (1996) 1.04
Loss of somatostatin-like immunoreactivity in the frontal cortex of Alzheimer patients carrying the apolipoprotein epsilon 4 allele. Neurosci Lett (1998) 1.04
AD2, a phosphorylation-dependent monoclonal antibody directed against tau proteins found in Alzheimer's disease. Brain Res Mol Brain Res (1996) 1.00
Investigation of tubulin fibers formed during microtubule polymerization cycles. FEBS Lett (1977) 1.00
Similar brain tau pathology in DM2/PROMM and DM1/Steinert disease. Neurology (2005) 1.00
Hyperphosphorylation of tau is mediated by ERK activation during anticancer drug-induced apoptosis in neuroblastoma cells. J Neurosci Res (2001) 0.99
Alzheimer's disease: a new evidence for common epitopes between microtubule associated protein Tau and paired helical filaments (PHF): demonstration at the electron microscope level by a double immunogold labelling. Virchows Arch A Pathol Anat Histopathol (1988) 0.98
Immunohistochemical identification of thrombospondin in normal human brain and in Alzheimer's disease. Am J Pathol (1992) 0.97
Proteasome inhibition and Tau proteolysis: an unexpected regulation. FEBS Lett (2005) 0.97
Correlation between microscopical changes and Tau 64 and 69 biochemical detection in senile dementia of the Alzheimer type. Tau 64 and 69 are reliable markers of the neurofibrillary degeneration. Acta Neuropathol (1990) 0.96
Alterations in neurofilament protein immunoreactivity in human hippocampal neurons related to normal aging and Alzheimer's disease. Neuroscience (1994) 0.95
Phosphorylation of Tau proteins: a major event during the process of neurofibrillary degeneration. A comparative study between Alzheimer's disease and Down's syndrome. Brain Res (1990) 0.94
Expression of ETS proto-oncogenes in astrocytes in human cortex. Brain Res (1988) 0.93
A novel presenilin-2 splice variant in human Alzheimer's disease brain tissue. J Neurochem (1999) 0.93
Relevance of the quantification of apolipoprotein E in the cerebrospinal fluid in Alzheimer's disease. Neurosci Lett (1996) 0.92
Phosphorylated serine422 on tau proteins is a pathological epitope found in several diseases with neurofibrillary degeneration. Acta Neuropathol (1999) 0.92
Association of ATP synthase alpha-chain with neurofibrillary degeneration in Alzheimer's disease. Neuroscience (2003) 0.92
Biochemical staging of synucleinopathy and amyloid deposition in dementia with Lewy bodies. J Neuropathol Exp Neurol (2006) 0.92
Observation of morphological relationships between angiopathic blood vessels and degenerative neurites in Alzheimer's disease. Virchows Arch A Pathol Anat Histopathol (1987) 0.91
ApoE synthesis in human neuroblastoma cells. Neurobiol Dis (1997) 0.90
Biochemical mapping of neurofibrillary degeneration in a case of progressive supranuclear palsy: evidence for general cortical involvement. Acta Neuropathol (1994) 0.90
Endothelin-converting enzyme-1 is expressed in human cerebral cortex and protects against Alzheimer's disease. Mol Psychiatry (2004) 0.90
Alzheimer's disease: glycolytic pretreatment dramatically enhances immunolabeling of senile plaques and cerebrovascular amyloid substance. Lab Invest (1989) 0.90
Binding of secreted human neuroblastoma proteoglycans to the Alzheimer's amyloid A4 peptide. Brain Res (1993) 0.89
Neurofibrillary degeneration in amyotrophic lateral sclerosis/parkinsonism-dementia complex of Guam. Immunochemical characterization of tau proteins. Am J Pathol (1995) 0.89
Immunocytochemical characterization of Tau proteins during cerebral aging of the lemurian primate Microcebus murinus. C R Acad Sci III (1995) 0.89
The immunohistochemical evidence of amyloid diffuse deposits as a pathological hallmark in Alzheimer's disease. J Gerontol (1991) 0.88
Synthesis and regulation of apolipoprotein E during the differentiation of human neuronal precursor NT2/D1 cells into postmitotic neurons. Exp Neurol (2000) 0.88
Neurofibrillary tangles in Gerstmann-Sträussler-Scheinker syndrome with the A117V prion gene mutation. J Neurol Neurosurg Psychiatry (1997) 0.87
Rapid tau protein dephosphorylation and differential rephosphorylation during cardiac arrest-induced cerebral ischemia and reperfusion. J Cereb Blood Flow Metab (2000) 0.87
Phosphorylation of specific sets of tau isoforms reflects different neurofibrillary degeneration processes. FEBS Lett (1998) 0.87
Neuronal localization of copper-zinc superoxide dismutase protein and mRNA within the human hippocampus from control and Alzheimer's disease brains. Free Radic Res Commun (1991) 0.87
Neuroimaging outcomes in clinical trials in Alzheimer's disease. J Nutr Health Aging (2009) 0.86
Parkinson's disease and Alzheimer's disease: neurodegenerative disorders due to brain antioxidant system deficiency? Adv Exp Med Biol (1990) 0.86
Association between the low density lipoprotein receptor-related protein (LRP) and Alzheimer's disease. Neurosci Lett (1997) 0.86
Mapping of neurofibrillary degeneration in Alzheimer's disease: evaluation of heterogeneity using the quantification of abnormal tau proteins. Acta Neuropathol (1992) 0.86
Binding of vascular heparan sulfate proteoglycan to Alzheimer's amyloid precursor protein is mediated in part by the N-terminal region of A4 peptide. Brain Res (1993) 0.85
Neuronal-specific expression of human copper-zinc superoxide dismutase gene in transgenic mice: animal model of gene dosage effects in Down's syndrome. Brain Res (1991) 0.85
Dementia in Parkinson's disease: biochemical evidence for cortical involvement using the immunodetection of abnormal Tau proteins. Ann Neurol (1993) 0.85
[Alzheimer's disease: study of the distribution of tau proteins constituting helical filament pairs in human central nervous tissue]. C R Acad Sci III (1988) 0.84
A double-labeling immunohistochemical study of tau exon 10 in Alzheimer's disease, progressive supranuclear palsy and Pick's disease. Acta Neuropathol (2000) 0.84
Tau aggregates are abnormally phosphorylated in inclusion body myositis and have an immunoelectrophoretic profile distinct from other tauopathies. Neuropathol Appl Neurobiol (2004) 0.83
Cortical angiopathy in Alzheimer's disease: the formation of dystrophic perivascular neurites is related to the exudation of amyloid fibrils from the pathological vessels. Virchows Arch A Pathol Anat Histopathol (1988) 0.83
Two-dimensional characterization of paired helical filament-tau from Alzheimer's disease: demonstration of an additional 74-kDa component and age-related biochemical modifications. J Neurochem (1997) 0.83
Presence of abnormally phosphorylated Tau proteins in the entorhinal cortex of aged non-demented subjects. Neurosci Lett (1992) 0.83
Intermediate filament proteins in mouse brain cells cultured in the presence or absence of fetal calf serum. Exp Cell Res (1982) 0.83
The proprotein convertase PC2 is involved in the maturation of prosomatostatin to somatostatin-14 but not in the somatostatin deficit in Alzheimer's disease. Neuroscience (2003) 0.83
Dystrophic peptidergic neurites in senile plaques of Alzheimer's disease hippocampus precede formation of paired helical filaments. Brain Res (1989) 0.83
Characterization of mammalian neurofilament subunits by circular dichroism. Biochim Biophys Acta (1982) 0.83
Amyotrophic lateral sclerosis/parkinsonism-dementia complex of Guam: quantitative neuropathology, immunohistochemical analysis of neuronal vulnerability, and comparison with related neurodegenerative disorders. Acta Neuropathol (1994) 0.82
Anti-PHF antibodies: an immunohistochemical marker of the lesions of the Alzheimer's disease. Characterization and comparison with Bodian's silver impregnation. Virchows Arch A Pathol Anat Histopathol (1985) 0.82
Progressive transformation of the cytoskeleton associated with normal aging and Alzheimer's disease. Brain Res (1992) 0.82
Evidence for apolipoprotein E epsilon 4 association in early-onset Alzheimer's patients with late-onset relatives. Am J Med Genet (1995) 0.82
Alzheimer's disease: microtubule-associated proteins 2 (MAP 2) are not components of paired helical filaments. FEBS Lett (1989) 0.82
Synthesis of apolipoprotein E (ApoE) mRNA by human neuronal-type SK N SH-SY 5Y cells and its regulation by nerve growth factor and ApoE. Neurosci Lett (1999) 0.82
Alzheimer-specific epitope of AT100 in transfected cell lines with tau: toward an efficient cell model of tau abnormal phosphorylation. Neurosci Lett (1998) 0.82
Coexistence of reactive plasticity and neurodegeneration in Alzheimer diseased brains. Histol Histopathol (2004) 0.82
Non-Alzheimer degenerative dementias. Curr Opin Neurol (1998) 0.81
Pathological tau phenotypes. The weight of mutations, polymorphisms, and differential neuronal vulnerabilities. Ann N Y Acad Sci (2000) 0.81
Applications of chemical cleavage procedures to the peptide mapping of neurofilament triplet protein bands in sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Anal Biochem (1986) 0.81
Distribution of neurofibrillary tangles and senile plaques in the cerebral cortex in postencephalitic parkinsonism. Neurosci Lett (1992) 0.80
Pathological tau proteins in postencephalitic parkinsonism: comparison with Alzheimer's disease and other neurodegenerative disorders. Ann Neurol (1997) 0.80
Electrophysiological effects of 25-35 amyloid-beta-protein on guinea-pig lateral septal neurons. Neurosci Lett (1993) 0.80
Transformation of degenerating neurofibrils into amyloid substance in Alzheimer's disease: histochemical and immunohistochemical studies. J Neurol Sci (1987) 0.80
Dementia in the oldest-old: quantitative analysis of 12 cases from a psychiatric hospital. Dementia (1995) 0.80
Increase of cdk5 is related to neurofibrillary pathology in progressive supranuclear palsy. Neurology (2002) 0.80
[Alzheimer's disease: immunohistochemical characterization of cerebral amyloid deposits]. C R Acad Sci III (1989) 0.80
[Direct demonstration of abnormal phosphorylation of Tau microtubular proteins in Alzheimer's disease]. C R Acad Sci III (1989) 0.79
Chemical modification of thiol group(s) in protein: application to the study of anti-microtubular drugs binding. Comp Biochem Physiol B (1987) 0.79
Dystrophic neuropeptidergic neurites in senile plaques of Alzheimer's disease precede formation of paired helical filaments. Acta Neurol Belg (1990) 0.79
Optimization of an alcian blue dot-blot assay for the detection of glycosaminoglycans and proteoglycans. Anal Biochem (1991) 0.79
Tau marker? Nature (1990) 0.79
The isolation of brain 10 nm filament polypeptides from urea-extracts of brain white matter. FEBS Lett (1979) 0.79
Influence and optimisation of operating parameters with a new binder in wet granulation. I: use in powder form. Eur J Pharm Biopharm (1998) 0.79
Are alpha-1-antichymotrypsin and inter-alpha-trypsin inhibitor peripheral markers of Alzheimer's disease? J Neurol Neurosurg Psychiatry (1991) 0.78